| 前收市價 | 12.23 |
| 開市 | 12.15 |
| 買盤 | 12.62 x 800 |
| 賣出價 | 12.65 x 400 |
| 今日波幅 | 12.01 - 12.65 |
| 52 週波幅 | 10.87 - 83.60 |
| 成交量 | |
| 平均成交量 | 1,284,339 |
| 市值 | 1.36B |
| Beta 值 (5 年，每月) | 0.43 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.95 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 27.33 |
ZacksNovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
NovoCure (NVCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksNovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade
NovoCure (NVCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Motley FoolWhy NovoCure Stock Soared 18.3% This Week
Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.
